Search
for
Sort by
Research 61–90 of 289
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- The Hirsute Woman: Challenges in Evaluation and Management
- Roles of steroid sulfatase in brain and other tissues
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Oestrogen receptor evaluation in Pomeranian dogs with hair cycle arrest (alopecia X) on melatonin supplementation
- What is the Rationale for Androgen Therapy for Women?
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Genetic basis of polycystic ovary syndrome
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Skin diseases in consequence of endocrine alterations
- Current aspects of polycystic ovary syndrome: A literature review
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Oligomenorrhoea in Exercising Women
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Testosterone Treatment in Women – An Overview
- Treatment of hyperandrogenism in women
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Post-finasteride syndrome – does it really exist?
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- The role of androgens in hormone replacement therapy
- Association of Polycystic Ovarian Syndrome (PCOS) With Vaginal Microbiome Dysbiosis: A Scoping Review
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men